NCT05022836

Brief Summary

Pulse oximetry screening (POS) for critical congenital heart diseases (CCHD) could identify 90% of these infants. However, this approach is not designed to detect cardiac defects without hypoxemia, especially congenital malformations of aorta (CMoA). More than 60% of CMoA was late diagnosed. Infants with CMoA were supposed to present with blood pressure (BP) gradient between four limbs. But a large sample size retrospective study of four-limb BP screening showed a negative result. The possible reason is that this study ran in population with a very low risk of CMoA. Whether four-limb BPs measurement could be used in infants with high risk of congenital malformation of aorta is still to be determined. The investigators retrospectively collected four-limb BPs, which was prospectively measured, in infants with high risk of CMoA. These data were divided into two groups, the discovery group and the validation group. The best cutoff of four-limb BP gradient was generated by Youden Index. The BP gradients by age were analyzed. Pre-operative hypotension and post-operative hypertension were also analyzed.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,604

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2013

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2013

Completed
7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 20, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 26, 2021

Completed
Last Updated

September 1, 2021

Status Verified

August 1, 2021

Enrollment Period

7 years

First QC Date

August 20, 2021

Last Update Submit

August 27, 2021

Conditions

Keywords

Congenital Heart DiseaseCoarctation of AortaInterrupted Aortic ArchHypoplasia of AortaBlood Pressurescreening

Outcome Measures

Primary Outcomes (1)

  • The cutoff of four-limb BPs gradient to diagnose CMoA

    ROC curve and Youden Index were used in the discovery group and the validation group to spot the optimal cutoff of BP gradient.

    at admission

Secondary Outcomes (1)

  • The accuracy of four-limb BPs measurement to predict CMoA

    at admission

Interventions

Four-limb blood pressures were measured by certificated nurses at admission.

Also known as: Echocardiogram or cardiac computed tomography results were used as the gold standard.

Eligibility Criteria

Age0 Days - 1 Year
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Infants admitted to the Guangdong Provincial People's Hospital between January 1st, 2013 and December 31st, 2019, who were suspected as having congenital heart disease, were enrolled in the study. Four-limb BPs in infants of confirmed or suspected CCHD admitted at our hospital were prospectively collected at admission following the Pediatric Department protocol for CCHD infants in which all infants with high risk of CCHD, defined as confirmed or suspected CCHD by clinical teams, were screened by measuring four-limb BPs by certificated nurses. Suspected CCHD was defined as unreasonable low SpO2, cyanosis, murmur, suspected CHD by prenatal ultrasound or postnatal echocardiography at other hospitals, and unexplained poor cardiac output.

You may qualify if:

  • Infants admitted to the Guangdong Provincial People's Hospital between January 1st, 2013 and December 31st, 2019, who were suspected as having congenital heart disease, were enrolled in the study.

You may not qualify if:

  • Infants without four-limb blood pressures measurement or without echocardiogram and cardiac computed tomography results were excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Aortic CoarctationHeart Defects, Congenital

Interventions

Echocardiography

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Cardiac Imaging TechniquesDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisUltrasonographyHeart Function TestsDiagnostic Techniques, Cardiovascular

Study Officials

  • Yifei Wang, MD

    Guangdong Provincial People's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy director of the Neonatology Department, Principal Investigator

Study Record Dates

First Submitted

August 20, 2021

First Posted

August 26, 2021

Study Start

January 1, 2013

Primary Completion

December 31, 2019

Study Completion

June 25, 2021

Last Updated

September 1, 2021

Record last verified: 2021-08